How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised
article has not abstract
Vyšlo v časopise:
How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised. PLoS Med 8(8): e32767. doi:10.1371/journal.pmed.1001072
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001072
Souhrn
article has not abstract
Zdroje
1. International Committee of Medical Journal Editors 1985 Guidelines on authorship. BMJ 291 722
2. International Committee of Medical Journal Editors 2011 Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publications. Available: http://www.icmje.org/. Accessed 6 July 2011
3. DavidoffFDeAngelisCDDrazenJMNichollsMGHoeyJ 2001 Sponsorship, authorship and accountability. CMAJ 165 786 788
4. De AngelisCDDrazenJMFrizelleFAHaugCHoeyJ 2005 Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet 365 1827 1829
5. DrazenJMde LeeuwPWLaineCMulrowCDeAngelisCD 2010 Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form. N Engl J Med 363 188 189
6. MathesonAD 2008 Corporate science and the husbandry of scientific and medical knowledge by the pharmaceutical industry. BioSocieties 3 355 382
7. Fugh-BermanAJ 2010 The haunting of medical journals: how ghostwriting sold “HRT”. PLoS Med 7 9 e1000335 doi:10.1371/journal.pmed.1000335
8. The PLoS Medicine Editors 2009 Ghostwriting: the dirty little secret of medical publishing that just got bigger. PLoS Med 6 9 e1000156 doi:10.1371/journal.pmed.1000156
9. SismondoSDoucetM 2010 Publication ethics and the ghost management of medical publication. Bioethics 24 273 283
10. EgilmanDDruarN 2011 Corporate versus public interests: community responsibility to defend scientific integrity. International Journal of Occupational and Environmental Health 17 181 185
11. Moynihan R 2008 Key opinion leaders: independent experts or drug representatives in disguise? BMJ 336 1402 1403
12. RennieDYankVEmanuelL 1997 When authorship fails. A proposal to make contributors accountable. JAMA 278 7 579 585
13. SmithR 1997 Authorship is dying: long live contributorship. BMJ 315 696
14. World Association of Medical Editors 2005 Ghost writing initiated by commercial companies. Available: http://www.wame.org/resources/policies#ghost. Accessed 6 July 2011
15. Council of Science 2009 White paper on promoting integrity in scientific journal publications. Available: http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3355. Accessed 6 July 2011
16. International Society for Medical Publication Professionals Issues and Actions Committee 2010 Professional medical writing. Available: http://www.ismpp.org/initiatives/Files/ISMPP_Ghost_Writing_vs_Professional_Medical_Writing.pdf. Accessed 6 July 2011
17. European Medical Writers Association Ghostwriting positioning statement. Available: http://www.emwa.org/Home/Ghostwriting-Positioning-Statement.html. Accessed 6 July 2011
18. American Medical Writers Association 2009 AMWA ethics FAQs. Available: http://www.amwa.org/default.asp?Mode=DirectoryDisplay&DirectoryUseAbsoluteOnSearch=True&id=466. Accessed 6 July 2011
19. IlakovacVFisterKMarusicMMarusicA 2007 Reliability of disclosure forms of authors' contributions. CMAJ 176 41 46
20. Pharmaceu Reasearch and Manufacturers of America 2009 Principles on conduct of clinical trials. Communication of clinical trial results. Washington (D.C.)Pharmaceutical Research and Manufacturers of America Available: http://www.phrma.org/sites/default/files/105/042009_clinical_trial_principles_final.pdf. Accessed 6 July 2011
21. GrafCBattistiWPBridgesDBruce-WinklerVConatyJM 2009 Research methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 339 b4330 doi:10.1136/bmj.b4330
22. JacobsAWagerE 2005 European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 21 2 317 322
23. GøtzschePCKassirerJPWoolleyKLWagerEJacobsA 2009 What should be done to tackle ghostwriting in the medical literature? PLoS Med 6 2 e1000023 doi:10.1371/journal.pmed.1000023
24. British Medical Journal 2011 Article submission. Provenance of articles. Available : http://resources.bmj.com/bmj/authors/authors/article-submission/submitting-an-article-to-the-bmj#provenance. Accessed 6 July 2011
25. World Association of Medical Editors 2007 Authorship. Available: http://www.wame.org/resources/policies#authorship. Accessed 6 July 2011
26. Neurology 2010 Information for authors. Available: http://www.neurology.org/misc/auth2.xhtml. Accessed 6 July 2011
27. Proceedings of the National Academy of Sciences 2011 Information for authors. Journal policies. Authorship. Available: http://www.pnas.org/site/misc/iforc.shtml#ii. Accessed 6 July 2011
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 8
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
- Are HIV Epidemics among Men Who Have Sex with Men Emerging in the Middle East and North Africa?: A Systematic Review and Data Synthesis
- Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis
- Being the Ghost in the Machine: A Medical Ghostwriter's Personal View